Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $9.9800 (-1.77%) ($9.9800 - $9.9800) on Thu. Apr. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.88% (three month average) | RSI | 32 | Latest Price | $9.9800(-1.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.5% a day on average for past five trading days. | Weekly Trend | BCRX declines -12.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(37%) ARKG(35%) ARKK(35%) | Factors Impacting BCRX price | BCRX will decline at least -3.44% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) IGOV(-6%) TBT(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.44% (StdDev 6.88%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.53(-195.49%) | Resistance Level | $11.61 | 5 Day Moving Average | $10.04(-0.6%) | 10 Day Moving Average | $10.68(-6.55%) | 20 Day Moving Average | $11.61(-14.04%) | To recent high | -26.8% | To recent low | 35.1% | Market Cap | $1.761b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |